SHUTTLE PHARMACEUTICALS HOLDINGS, INC. Interest Expense
SHUTTLE PHARMACEUTICALS HOLDINGS, INC. (SHPH) reported Interest Expense of $623.47 thousand for the 3-month period ending 2023-09-30, per its 10-Q filed 2024-11-13.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2024-11-13
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. interest expense for the quarter ending 2023-09-30 was $623.47K.
| Period end | Interest Expense 3 month | Interest Expense 9 month |
|---|---|---|
| 2023-09-30 | $623.47K 10-Q · filed 2024-11-13 | $1.95M 10-Q · filed 2024-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |